⧫ Drug delivery technology platform development for AI-powered personalised cancer immunotherapy⧫ Led a multidisciplinary team: Molecular Biology | Chemistry | Medical Engineering⧫ Management of R&D projects and budget⧫ Investment evaluation to support corporate decision-makingHighlights of Transferable Skills￮ Analytical & organisational skills: background research, evidence-based data interpretation and presentation, new target assessment, teamwork, time management￮ Supervision & team building: leading a boutique team of PhD professionals with diverse expertise￮ IT literate: Microsoft Office Suite, Adobe Suite, EndNote, PyMOL, CCP4 Suite, AlphaFold Colab, a range of bioinformatics online tools

Immunotherapy company focused on novel bi-specific antibody development for haematological malignancies and solid tumours⧫ New target assessment: primary & secondary research, scientific data analysis, roundtable discussion 
 ⧫ Assay development: information extraction, POC experiment design and execution, data interpretation
 ⧫ Antibody engineering: antibody format design, robust cloning techniques, validation⧫ Supported data documenting for stakeholders

Crick-GSK Biomedical LinkLabs ⧫ Executed multiple cross-organisational projects for 4 years between academia (Crick Institute) and 
 pharmaceutical (GSK), worked alongside GSK scientists, presented in milestone meetings, internal and 
 external seminars to focused and broader target audience
 ⧫ Established co-crystals of domain antibody-antigen as a fragment screening platform (first for E3 ligase)
 ⧫ Innovative approach to study structures and functions of ubiquitin ligases
 ⧫ Cultivated professional relationships with external biopharma scientists and internal technology platformHighlights of Scientific Expertise￮ X-ray crystallography, compound soaking
￮ Domain antibody discovery, phage display, high throughput expression system￮ Protein-protein & protein-ligand interactions: ITC, SPR, BLI, co-IP￮ Protein purification and characterisation: Affinity/IEX/HIC/SEC, ÄKTA equipment & UNICORN, PAGE, Western Blot￮ Protein expression: bacterial and mammalian cell systems

Crick-GSK Biomedical LinkLabs⧫ Domain antibody discovery and dAb-Ag evaluation
 ⧫ Effective communication with multidisciplinary experts and integrated in pharma working mindset 
 ⧫ Invited to publish personal and professional experience of the inaugural Crick-GSK collaboration

Neuropilin 2 | Regulatory Zinc | VEGFA | Cardiovascular Development & Tumoregenesis⧫ Funded by British Heart Foundation (2y2m)⧫ First to discover unique regulatory zinc binding that detriments Neuropilin 2 and the rescue effect of heparin
 ⧫ First to describe the ligand (VEGFA) binding to Neuropilin 2 at atomic resolution
Telomerase inhibition by a quadruplex ligand as an anti-tumour strategy ⧫ Funded by Pancreatic Cancer Research Fund (3m)⧫ Cancer and somatic cell culture⧫ Cytotoxicity assay, Senescence cell staining assay⧫ Supervised Erasmus student (MSc)